The effects of HIV self-testing on HIV incidence and awareness of status among men who have sex with men in the United States: Insights from a novel compartmental model.

Alex Viguerie, Chaitra Gopalappa, Cynthia M Lyles, Paul G Farnham
Author Information
  1. Alex Viguerie: Centers for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of HIV Prevention (DHP), Quantitative Sciences Branch (QSB), USA. Electronic address: xjm9@cdc.gov.
  2. Chaitra Gopalappa: Centers for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of HIV Prevention (DHP), Quantitative Sciences Branch (QSB), USA; Department of Mechanical and Industrial Engineering, University of Massachusetts Amherst, Amherst, MA 01003, USA.
  3. Cynthia M Lyles: Centers for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of HIV Prevention (DHP), Quantitative Sciences Branch (QSB), USA.
  4. Paul G Farnham: Centers for Disease Control and Prevention (CDC), National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Division of HIV Prevention (DHP), Quantitative Sciences Branch (QSB), USA.

Abstract

BACKGROUND: The OraQuick In-Home HIV self-test represents a fast, inexpensive, and convenient method for users to assess their HIV status. If integrated thoughtfully into existing testing practices, accompanied by efficient pathways to formal diagnosis, self-testing could enhance both HIV awareness and reduce HIV incidence. However, currently available self-tests are less sensitive, particularly for recent infection, when compared to gold-standard laboratory tests. It is important to understand the impact if some portion of standard testing is replaced by self-tests. We used a compartmental model to evaluate the effects of self-testing in diverse scenarios among gay, bisexual and other men who have sex with men (MSM) in the United States for the period 2020-2030, and to understand which scenarios maximize the advantages of self-testing.
METHODS: We introduced a novel 4-compartment model for HIV self-testing. We employed the model under different screening rates, self-test proportions, and delays to diagnosis for those identified through self-tests to determine the potential effects of self-testing on HIV incidence and awareness of status when applied to the US MSM population. We studied scenarios in which self-tests supplement laboratory-based tests, with no replacement, and scenarios in which some replacement occurs. We also examined how future improvements in self-test sensitivity may affect our results.
RESULTS: When HIV self-tests are supplemental rather than substitutes for laboratory-based testing, self-testing can decrease HIV incidence among MSM in the US by up to 10���% and increase awareness of status among MSM from 85���% to 91���% over a 10-year period, provided linkage to care and formal diagnosis occur promptly following a positive self-test (90 days or less). As self-tests replace a higher percentage laboratory-based testing algorithms, increases in overall testing rates were necessary to ensure reductions in HIV incidence. However, such needed increases were relatively small (under 10���% for prompt engagement in care and moderate levels of replacement). Improvements in self-test sensitivity and/or decreases in the detection period may further reduce any necessary increases in overall testing by up to 40���%.
CONCLUSIONS: If properly utilized, self-testing can provide significant long-term reductions to HIV incidence and improve awareness of HIV status. Ensuring that self-testing increases overall testing and that formal diagnosis and engagement in care occur promptly following a positive self-test are necessary to maximize the benefits of self-testing. Future improvements in self-test sensitivity and reductions in the detection period would further reduce HIV incidence and the potential risks associated with replacing laboratory tests with self-tests.

Keywords

References

  1. Lancet Reg Health Am. 2022 Mar;7:100159 [PMID: 34961858]
  2. Lancet HIV. 2018 Aug;5(8):e438-e447 [PMID: 30025681]
  3. AIDS Behav. 2018 Jan;22(1):190-201 [PMID: 28831616]
  4. Bull Math Biol. 2023 Mar 29;85(5):36 [PMID: 36988763]
  5. J Acquir Immune Defic Syndr. 2022 Apr 1;89(4):374-380 [PMID: 35202046]
  6. J Public Health Manag Pract. 2022 Mar-Apr 01;28(2):152-161 [PMID: 34225307]
  7. Lancet HIV. 2017 Jun;4(6):e241-e250 [PMID: 28219619]
  8. MMWR Recomm Rep. 2006 Sep 22;55(RR-14):1-17; quiz CE1-4 [PMID: 16988643]
  9. J Acquir Immune Defic Syndr. 2018 Aug 15;78(5):505-512 [PMID: 29697595]
  10. Sex Transm Dis. 2014 Jan;41(1):2-9 [PMID: 24335742]
  11. J Int Assoc Physicians AIDS Care (Chic). 2011 Nov-Dec;10(6):357-64 [PMID: 21527425]
  12. BMC Public Health. 2023 Apr 20;23(1):716 [PMID: 37081482]
  13. Epidemics. 2010 Jun;2(2):66-79 [PMID: 21352777]
  14. PLoS One. 2012;7(9):e44819 [PMID: 23024766]
  15. Ann Epidemiol. 2019 Jun;34:12-17 [PMID: 30967302]
  16. Sex Transm Dis. 2014 Jan;41(1):10-2 [PMID: 24326576]
  17. Epidemics. 2021 Dec;37:100518 [PMID: 34775299]
  18. JMIR Public Health Surveill. 2016 May 17;2(1):e22 [PMID: 27244769]
  19. MMWR Morb Mortal Wkly Rep. 2017 Aug 11;66(31):830-832 [PMID: 28796758]
  20. MMWR Morb Mortal Wkly Rep. 2022 Apr 01;71(13):489-494 [PMID: 35358168]
  21. Lancet. 2019 Jun 15;393(10189):2428-2438 [PMID: 31056293]
  22. JAMA. 2019 Mar 5;321(9):844-845 [PMID: 30730529]
  23. BMC Infect Dis. 2022 May 25;22(Suppl 1):494 [PMID: 35614397]
  24. J Int AIDS Soc. 2020 Jan;23(1):e25445 [PMID: 31960580]
  25. J Clin Virol. 2011 Dec;52 Suppl 1:S17-22 [PMID: 21981983]
  26. AIDS. 2008 May 31;22(9):1071-7 [PMID: 18520351]
  27. MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1322-1325 [PMID: 34555001]
  28. JAMA Intern Med. 2020 Jan 1;180(1):117-125 [PMID: 31738378]
  29. AIDS. 2019 Mar 15;33(4):701-708 [PMID: 30585840]
  30. Sex Transm Dis. 2021 Apr 1;48(4):299-304 [PMID: 33492100]
  31. N Engl J Med. 2016 Jul 21;375(3):229-39 [PMID: 27468059]
  32. PLoS One. 2013 Oct 23;8(10):e76878 [PMID: 24194848]
  33. Clin Infect Dis. 2022 Aug 24;75(1):e1145-e1153 [PMID: 35016216]
  34. Clin Infect Dis. 2021 Jun 1;72(11):e828-e834 [PMID: 33045723]
  35. J Acquir Immune Defic Syndr. 2005 Mar 1;38(3):241-53 [PMID: 15735440]
  36. Int J Epidemiol. 2016 Feb;45(1):140-50 [PMID: 26772869]

Grants

  1. CC999999/Intramural CDC HHS

MeSH Term

Humans
Male
HIV Infections
Homosexuality, Male
United States
Incidence
Self-Testing
Adult
HIV Testing
Mass Screening
Sexual and Gender Minorities

Word Cloud

Created with Highcharts 10.0.0HIVself-testingself-testtestingincidenceself-testsstatusawarenessdiagnosismodelscenariosamongmenMSMperiodincreasesformalreducetestseffectslaboratory-basedreplacementsensitivitycareoverallnecessaryreductionsHoweverlesslaboratoryunderstandcompartmentalsexUnitedmaximizenovelratespotentialUSimprovementsmaycan10���%occurpromptlyfollowingpositiveengagementdetectionBACKGROUND:OraQuickIn-Homerepresentsfastinexpensiveconvenientmethodusersassessintegratedthoughtfullyexistingpracticesaccompaniedefficientpathwaysenhancecurrentlyavailablesensitiveparticularlyrecentinfectioncomparedgold-standardimportantimpactportionstandardreplacedusedevaluatediversegaybisexualStates2020-2030advantagesMETHODS:introduced4-compartmentemployeddifferentscreeningproportionsdelaysidentifieddetermineappliedpopulationstudiedsupplementoccursalsoexaminedfutureaffectresultsRESULTS:supplementalrathersubstitutesdecreaseincrease85���%91���%10-yearprovidedlinkage90daysreplacehigherpercentagealgorithmsensureneededrelativelysmallpromptmoderatelevelsImprovementsand/ordecreases40���%CONCLUSIONS:properlyutilizedprovidesignificantlong-termimproveEnsuringbenefitsFuturerisksassociatedreplacingStates:InsightsHIV/AIDSMathematicalmodelingSelf-testing

Similar Articles

Cited By

No available data.